Nature's Sunshine Products (NATR) Q2 2026 Earnings Call Summary

1Key Financial Results and Metrics

Net Sales: $117 million, a 2% increase year-over-year (4% increase in constant currency).

Gross Margin: Improved to 73.7%, up nearly 200 basis points, the highest in over four years.

SG&A Expenses: $44.9 million (38.4% of net sales), up from $43.7 million a year ago, reflecting investments in strategic initiatives.

Adjusted EBITDA: $11.3 million, a slight increase of nearly 1%.

Cash Position: $82.5 million in cash and cash equivalents, with zero debt.

Share Repurchases: 113,000 shares repurchased for approximately $2.5 million, with $14.8 million remaining in the program.

2Strategic Updates and Business Highlights

Sales Growth Drivers: Growth was primarily driven by strong digital sales in North America (up 26%) and continued customer acquisition. Asia Pacific sales grew 5% in constant currency, despite a decline in China (down 20%).

Vision for Growth: The company is investing in digital expansion, consultant tools, market penetration, and new geographic markets. Key leadership appointments include Ruth Perkins as CFO and Janine Weber as President of North America.

Product Performance: Core products in gut health remain top sellers. The Synergy brand in APAC showed strong growth, particularly in Japan (up 50%).

3Forward Guidance and Outlook

Revised Sales Guidance: Lowered to $490 million - $500 million from $500 million - $515 million due to currency fluctuations and challenges in China.

EBITDA Guidance: Adjusted to $48 million - $52 million from $50 million - $54 million.

Long-term Goals: Aim to double sales to $1 billion and improve EBITDA margin to 15%.

4Bad News, Challenges, or Points of Concern

China Market Weakness: A significant decline in sales (down 20%) due to operational issues, contrasting with previous growth trends.

Direct Selling Pressure: The core direct selling business in North America has been underperforming, prompting a planned reinvigoration of the program.

SG&A Increase: Rising expenses may impact profitability in the short term as the company invests in growth initiatives.

5Notable Q&A Insights

Core Business Performance: The North American direct selling business has been soft, but digital sales are thriving. A major overhaul of the direct selling program is planned for early 2027.

Germany Launch: Initial sales expectations are modest ($1 million), but the market is seen as having significant long-term potential.

M&A Strategy: Future acquisitions will focus on supplement brands that can integrate into existing operations, with an emphasis on self-manufacturing capabilities and growth potential. Overall, Nature's Sunshine reported solid growth in Q2 2026, driven by digital sales and strategic investments, despite facing challenges in the Chinese market and a struggling direct selling segment. The company remains optimistic about its long-term growth prospects through its Vision for Growth strategy.